InvestorsHub Logo
Followers 101
Posts 13453
Boards Moderated 2
Alias Born 01/23/2004

Re: hardlesson post# 58563

Tuesday, 05/17/2022 5:39:06 PM

Tuesday, May 17, 2022 5:39:06 PM

Post# of 65593
I would like to know that too.

FDA Advisors...that's what I want to know...



“Dr. Aguilar’s expertise and years of experience in novel reagents and regenerative medicine will greatly benefit SOHM’s current and future pipelines.”

Dr. Aguilar has extensive research experience in areas focusing on pharmacology, molecular diagnostics, protein biochemistry, cell engineering, and genome editing



How is any of his experience beneficial to what "WE KNOW" of the type of drugs SHMN is working on?

Now this guy I get.

Wm. Dewey Rushing to serve on the Advisory Board as our expert on Validation and Compliance offering his extensive expertise in pharmaceutical Quality Validation and cGMP Compliance.

Mr. Rushing has over 20 years of experience in pharmaceutical Quality Validation and cGMP Compliance. He spent 4 years with the U.S. Food & Drug Administration as a Trained Investigator and instructor for the Los Angeles District. He is experienced in the technology transfer of biological and pharmaceutical products.



The other is confusing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHMN News